Type 1 Diabetes in Pregnancy

Diabetes management has been revolutionized by automated insulin delivery (AID) systems, which are now the preferred method of insulin therapy for nonpregnant people with type 1 diabetes (T1D). This chapter provides detailed information regarding AID systems to assist clinicians in supporting the growing population of gravidas with T1D who elect for off-label use of AID systems in pregnancy. First, we review the details of the 5 AID systems that are currently available for use in the United States, including unique features of each system and how they vary with regards to delivery of basal, prandial, and correctional insulin. Second, we summarize the evidence from observational and interventional studies examining the use of these systems in the antepartum, intrapartum, and postpartum periods. Finally, we provide practical tips regarding use of AID systems in pregnancy, with a focus on assistive techniques that can support the unique demands of gestation.

Authors

Institutions

Publication Details

Journal
Clinical Obstetrics & Gynecology
Published
2026-04-13
DOI
https://doi.org/10.1097/grf.0000000000000993
Primary Topic
Gestational Diabetes Research and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Type 1 Diabetes in Pregnancy

Kelly Engle, Nasim C. Sobhani, Emily A. Rosenberg
Clinical Obstetrics & Gynecology
Gestational Diabetes Research and Management
article

Type 1 Diabetes in Pregnancy

Kelly Engle, Nasim C. Sobhani, Emily A. Rosenberg
article en

Abstract

Diabetes management has been revolutionized by automated insulin delivery (AID) systems, which are now the preferred method of insulin therapy for nonpregnant people with type 1 diabetes (T1D). This chapter provides detailed information regarding AID systems to assist clinicians in supporting the growing population of gravidas with T1D who elect for off-label use of AID systems in pregnancy. First, we review the details of the 5 AID systems that are currently available for use in the United States, including unique features of each system and how they vary with regards to delivery of basal, prandial, and correctional insulin. Second, we summarize the evidence from observational and interventional studies examining the use of these systems in the antepartum, intrapartum, and postpartum periods. Finally, we provide practical tips regarding use of AID systems in pregnancy, with a focus on assistive techniques that can support the unique demands of gestation.

Clinical Obstetrics & GynecologyVol. 69(2)
Medical University of South Carolina (US), Society for Maternal-Fetal Medicine (US)
Good health and well-being
Openalex Percentile: Top 26%
Gestational Diabetes Research and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Type 1 Diabetes in Pregnancy — Kelly Engle, Nasim C. Sobhani, et al. · Clinical Obstetrics & Gynecology (2026) | TGRS Research Map | TGRS